⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17068306 | 1.00 | — | — | |
| SCHEMBL14950779 | 1.00 | — | — | |
| SCHEMBL18467421 | 1.00 | — | — | |
| SCHEMBL17068305 | 1.00 | — | — | |
| SCHEMBL18467490 | 0.84 | L3MBTL1 (0.33) | — | |
| SCHEMBL18467489 | 0.84 | L3MBTL1 (0.33) | — | |
| SCHEMBL18467491 | 0.84 | L3MBTL1 (0.33) | — | |
| SCHEMBL14950801 | 0.84 | L3MBTL1 (0.33) | — | |
| SCHEMBL14950802 | 0.84 | L3MBTL1 (0.33) | — | |
| SCHEMBL10210058 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9546160-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-01-17 | — | — | US | disclosed |
| US-20160338999-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-11-24 | — | — | US | disclosed |
| US-20130121957-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2013-05-16 | — | — | US | disclosed |